BIOLOGY 2F03 Lecture Notes - Lecture 7: Gray Platelet Syndrome, Platelet Alpha-Granule, Dense Granule
intracellular disorders are subclassified by what storage granule is problematic
intracellular disorders are more common but only give mild bleeding. platelet count and lifespan are
usually normal and ATP:ADP ratio is an important diagnostic tool.
storage pool disease - Dense granule deficiency
• Idiopathic (non-albino type)
• hermansky-pudlak syndrome
o AR disease associated with mild bleeding
o due to membrane and content abnormalities for dense granules
o oculocutaneous albinism and very bad nystagmus are features – treat with tranexamic
acid
• chediak higashi syndrome
o AR disease associated with increased risk of infections; treat with bone marrow
translpant
• wiskott-aldrich syndrome
o due to defective WASP protein expression
o associated with eczema, immune deficiency and requires splenectomy or BMT
storage pool disease = alpha granule deficiency
• Grey platelet syndrome
o AD rare disease where alpha granules are absent/empty (so platelets appear grey on
blood film)
• quebec platelet disorder
o AD disease associated with alpha granule multimerin deficiency; reduced contents
• combined storage pool disease
defects of thromboxane generation are due to COX/ thromboxane synthetase deficiencies
defects in signal transduction can be suspected if you defective aggregation responses to all agonists
4. treatment of hereditary platelet disorders requires specialist care
• Supportive measures (avoid aspirin, NSAIDs, give tranexamic acid)
• DDAVP (but not in kids as it gives hyponatraemia)
• platelet transfusion – HLA match if they will need lifelong transfusion to avoid Ab synthesis
• rF8 for Haemophil/glanzmanns patients who have developed Abs
• BMT – usually just for Bernard soullier and glanzmanns; 10% mortality at least
1.20 – PREGNANCY OESTROGENS AND THE COAGULATION SYSTEM
1. Oestrogens are associated with an increased risk of VTE
Thrombotic changes associated with oestrogens
• Increased procoagulant activity
o stimulation of Fibrinogen, F7-11, vWF, protein C resistance
• Decreased anticoagulant activity
o Inhibition of protein S and antithrombin
o the pill reduces transcriptional synthesis of protein S
find more resources at oneclass.com
find more resources at oneclass.com